NGEN

$4.04

Market ClosedAs of Mar 17, 8:00 PM UTC

NervGen Pharma Corp., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease.

OverviewIntradayAnalysisPROIntelligencePROAsk AIPRO

Intraday

Custom Range:
to
No data available for this range. Intraday data may be limited by the exchange.

Recent News

Simply Wall St.
Feb 1, 2026

When Will NervGen Pharma Corp. (CVE:NGEN) Breakeven?

We feel now is a pretty good time to analyse NervGen Pharma Corp.'s ( CVE:NGEN ) business as it appears the company may...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.